Results 161 to 170 of about 138,627 (294)

Bezlotoxumab as Treatment for Recurrent/Chronic Clostridioides difficile Infection in Pediatric Stem Cell Transplant Recipients: A Multi‐Institutional Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Clostridioides difficile infection (CDI) represents a significant health risk to pediatric stem cell transplant (SCT) patients. In these patients, recurrent CDI is common, requiring prolonged antibiotic usage and increased hospitalization. Bezlotoxumab, a monoclonal antibody that targets the toxin responsible for CDI, has demonstrated efficacy
Aaron E. Fan   +8 more
wiley   +1 more source

Unexpected Falsely High Vancomycin Concentrations in a Patient with Endocarditis During Routine Therapeutic Drug Monitoring. [PDF]

open access: yesEur J Case Rep Intern Med
Galán-Caballero L   +6 more
europepmc   +1 more source

Therapeutic Effects of Phyllanthus urinaria L on Cisplatin‐Induced Acute Kidney Injury: Anti‐Inflammatory, Anti‐Apoptotic, and Anti‐Oxidative Action

open access: yesPediatric Discovery, EarlyView.
Phyllanthus urinaria L can alleviate cisplatin‐induced acute kidney injury by inhibiting inflammation, apoptosis and oxidative stress. ABSTRACT Acute kidney injury (AKI) is a prevalent and serious clinical challenge with limited specific treatments.
Qitong Guo   +8 more
wiley   +1 more source

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract Background Drug databases currently do not provide dosing guidance for sulbactam‐durlobactam in continuous renal replacement therapy. Herein, we present the first in vivo pharmacokinetic (PK) evaluation of sulbactam‐durlobactam during continuous venovenous hemofiltration (CVVH) in a patient with carbapenem‐resistant Acinetobacter baumannii ...
Wesley D. Kufel   +8 more
wiley   +1 more source

Vancomycin Prescribing in the Era of Vancomycin‐Resistant Enterococci [PDF]

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1995
openaire   +3 more sources

Cold Atmospheric Plasma for Water Disinfection: Mechanisms, Efficacy and Resistant Bacteria Inactivation

open access: yesPlasma Processes and Polymers, EarlyView.
Cold atmospheric plasma (CAP) is a promising method for inactivating antibiotic‐resistant bacteria in liquid environments. This review explores its mechanisms, treatment parameters, and efficacy, highlighting CAP's potential as a sustainable, resistance‐free disinfection alternative and its relevance for advancing water treatment and combating ...
Manca Lunder, Sebastian Dahle, Rok Fink
wiley   +1 more source

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers [PDF]

open access: green, 1990
Michael J. Rybak   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy